|
Recent Newsletters
FDA clears 2 new solutions, rules on omecamtiv mecarbil for HFrEF | AI model uses DNA to predict AFib, HF |
Medtronic & Abbott share new TAVR data | Addressing health disparities at the local level | A risky artificial sweetener |
FDA's warning about Trifecta heart valves | Heart attack deaths going down | A new-look device for PCI & TAVR |
News Alert: FDA warns that early deterioration is possible with Abbott's Trifecta heart valves |
Care Delivery Highlights: A key update on a recent recall | 4,000 TAVRs | Comprehensive heart teams |
Daily marijuana use increases CAD risk | Ongoing trends in PAD & CLI | Cardiologist honored with her own doll |
ChatGPT & cardiology | The rise of private equity-backed management companies | More from the last week |